Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology

Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology

Cell therapy utilizing chimeric antigen receptors (CARs) in conjunction with immune cells, primarily T lymphocytes, is known as CAR-T cell therapy. This innovative approach is revolutionizing the landscape of oncohaematology by precisely targeting specific antigens for elimination. However, despite...

Full description

Bibliographic Details
Main Authors: Candela Ceballos, Mª Cruz Viguria, Carlos Panizo, Juan Roberto Rodríguez-Madoz, Felipe Prósper
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Hematology
Subjects:
car t therapy
CAR T development
FDA approval
limitations and barriers
immunohematology
Online Access:https://www.frontiersin.org/articles/10.3389/frhem.2023.1217775/full

Internet

https://www.frontiersin.org/articles/10.3389/frhem.2023.1217775/full

Similar Items